| Model Descriptions on This Page | |
|
Graft Survival Model Description
|
Patient Survival Model Description |
| Living Donor Graft Survival Model Description | |||
| 1 Month after Transplant | |||
| Organ: Kidney | |||
| Adult (Age 18+) | |||
| 97.2% alive at 1 Month when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Congenital, Rare Familial, & Metabolic Disorders* | 0.8063 | 0.3565 | 0.0237 |
| Diagnosis: Diabetes* | 0.2690 | 0.1741 | 0.1224 |
| Diagnosis: Hypertensive Nephrosclerosis* | 0.1538 | 0.2149 | 0.4742 |
| Diagnosis: Other/Missing* | 0.2754 | 0.2082 | 0.1860 |
| Diagnosis: Polycystic Kidney Disease* | -0.0217 | 0.2513 | 0.9310 |
| Diagnosis: Renovascular & Other Vascular Diseases* | -0.6080 | 0.4271 | 0.1546 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.1496 | 0.2725 | 0.5830 |
| Donor Hispanic/Latino | -0.1095 | 0.3298 | 0.7399 |
| Donor age: 11-17 (ref==35-49) | -12.5973 | 1899.2431 | 0.9947 |
| Donor age: 18-34 (ref=35-49) | 0.1249 | 0.2190 | 0.5683 |
| Donor age: 50-64 (ref=35-49) | 0.2940 | 0.2677 | 0.2721 |
| Donor age: 65+ (ref=35-49) | 0.2152 | 1.0099 | 0.8313 |
| HLA mismatch: 0 mismatch (ref=3.5 mismatch) | 0.0062 | 0.1837 | 0.9733 |
| HLA mismatch: linear ** (ref=3.5 mismatch) | 0.0644 | 0.0470 | 0.1701 |
| HLA mismatch: missing (ref=3.5 mismatch) | 0.8196 | 0.2925 | 0.0051 |
| Ischemia time: linear (ref=average time**) | 0.0027 | 0.0320 | 0.9329 |
| Ischemia time: missing (ref=average time**) | -0.4193 | 0.6954 | 0.5465 |
| Ischemia time: quadratic (ref=average time**) | 0.0000 | 0.0009 | 0.9714 |
| Peak PRA: 10-79 (ref=<10) | -0.0117 | 0.2693 | 0.9653 |
| Peak PRA: 80-100 (ref=<10) | 0.6361 | 0.5173 | 0.2188 |
| Peak PRA: missing (ref=<10) | -0.0761 | 0.6002 | 0.8991 |
| Previous transplant of this organ type | 0.2278 | 0.2915 | 0.4345 |
| Recipient age: 18-34 (ref=35-49) | -0.0434 | 0.2433 | 0.8584 |
| Recipient age: 50-64 (ref=35-49) | -0.1020 | 0.2237 | 0.6484 |
| Recipient age: 65+ (ref=35-49) | 0.2593 | 0.2972 | 0.3829 |
| Recipient ethnicity: Hispanic/Latino (ref=Non-Hispanic/Non-Latino) | -0.2157 | 0.4237 | 0.6106 |
| Recipient female | 0.3634 | 0.1330 | 0.0063 |
| Recipient medical condition: hospitalized not in ICU (ref=not hospitalized) | 0.2162 | 0.3599 | 0.5480 |
| Recipient medical condition: in ICU (ref=not hospitalized) | 1.3684 | 0.7149 | 0.0556 |
| Year of ESRD treatment: missing (ref=years 3-5) | 1.7592 | 0.5252 | 0.0008 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | -0.3911 | 0.1547 | 0.0114 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | -0.2380 | 0.1826 | 0.1925 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | -0.3764 | 0.2744 | 0.1702 |
| Recipient age by donor age interaction: 18-34 and 18-34 (ref=35-49 and 35-49) | -0.1086 | 0.3432 | 0.7516 |
| Recipient age by donor age interaction: 18-34 and 50-64 (ref=35-49 and 35-49) | -0.4695 | 0.4588 | 0.3061 |
| Recipient age by donor age interaction: 18-34 and 65+ (ref=35-49 and 35-49) | -12.8409 | 992.2510 | 0.9897 |
| Recipient age by donor age interaction: 50-64 and 18-34 (ref=35-49 and 35-49) | 0.2247 | 0.3296 | 0.4954 |
| Recipient age by donor age interaction: 50-64 and 50-64 (ref=35-49 and 35-49) | -0.1100 | 0.3794 | 0.7719 |
| Recipient age by donor age interaction: 50-64 and 65+ (ref=35-49 and 35-49) | 0.0781 | 1.4353 | 0.9566 |
| Recipient age by donor age interaction: 65+ and 18-34 (ref=35-49 and 35-49) | -0.0315 | 0.6080 | 0.9586 |
| Recipient age by donor age interaction: 65+ and 50-64 (ref=35-49 and 35-49) | -0.6335 | 0.6890 | 0.3578 |
| Recipient age by donor age interaction: 65+ and 65+ (ref=35-49 and 35-49) | -0.7762 | 1.4498 | 0.5924 |
| Recipient age by recipient ethnicity interaction: 18-34 and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | 0.4870 | 0.4501 | 0.2793 |
| Recipient age by recipient ethnicity interaction: 50-64 and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | -0.4836 | 0.5707 | 0.3968 |
| Recipient age by recipient ethnicity interaction: 65+ and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | -0.3418 | 1.0801 | 0.7517 |
| Recipient sex by peak PRA interaction: female and 10-79 (ref=male and <10) | 0.2474 | 0.3285 | 0.4513 |
| Recipient sex by peak PRA interaction: female and 80+ (ref=male and <10) | -0.0246 | 0.5903 | 0.9667 |
| Recipient sex by peak PRA interaction: female and missing (ref=male and <10) | -12.7535 | 314.2162 | 0.9676 |
| * Reference for diagnosis group is glomerular diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Graft Survival Model Description | |||
| 1 Year after Transplant | |||
| Organ: Kidney | |||
| Adult (Age 18+) | |||
| 88.4% alive at 1 Year when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Congenital, Rare Familial, & Metabolic Disorders* | 0.2038 | 0.3137 | 0.5159 |
| Diagnosis: Diabetes* | 0.2180 | 0.1172 | 0.0628 |
| Diagnosis: Hypertensive Nephrosclerosis* | 0.1295 | 0.1427 | 0.3641 |
| Diagnosis: Other/Missing* | 0.1948 | 0.1430 | 0.1733 |
| Diagnosis: Polycystic Kidney Disease* | -0.3431 | 0.1874 | 0.0671 |
| Diagnosis: Renovascular & Other Vascular Diseases* | -0.3198 | 0.2407 | 0.1839 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.3354 | 0.1713 | 0.0502 |
| Donor Hispanic/Latino | -0.0331 | 0.2169 | 0.8787 |
| Donor age: 11-17 (ref==35-49) | -8.1707 | 147.9366 | 0.9560 |
| Donor age: 18-34 (ref=35-49) | -0.0370 | 0.0926 | 0.6894 |
| Donor age: 50-64 (ref=35-49) | 0.0259 | 0.1071 | 0.8088 |
| Donor age: 65+ (ref=35-49) | -0.1147 | 0.3640 | 0.7528 |
| Donor race: Asian (ref=White) | 0.3841 | 0.3927 | 0.3280 |
| Donor race: Black (ref=White) | 0.5305 | 0.2581 | 0.0398 |
| Donor race: Multi-racial, other, unknown or missing (ref=White) | 0.6692 | 0.2775 | 0.0159 |
| HLA mismatch: 0 mismatch (ref=3.5 mismatch) | -0.4078 | 0.1459 | 0.0052 |
| HLA mismatch: linear ** (ref=3.5 mismatch) | 0.1107 | 0.0301 | 0.0002 |
| HLA mismatch: missing (ref=3.5 mismatch) | 0.2294 | 0.2396 | 0.3384 |
| Ischemia time: linear (ref=average time**) | 0.0198 | 0.0193 | 0.3034 |
| Ischemia time: missing (ref=average time**) | -0.7695 | 0.4645 | 0.0976 |
| Ischemia time: quadratic (ref=average time**) | -0.0006 | 0.0009 | 0.5220 |
| Peak PRA: 10-79 (ref=<10) | -0.0632 | 0.1727 | 0.7143 |
| Peak PRA: 80-100 (ref=<10) | 0.9212 | 0.3013 | 0.0022 |
| Peak PRA: missing (ref=<10) | 0.2923 | 0.3698 | 0.4293 |
| Previous transplant of this organ type | 0.1136 | 0.2026 | 0.5751 |
| Recipient age: 18-34 (ref=35-49) | 0.0505 | 0.1192 | 0.6716 |
| Recipient age: 50-64 (ref=35-49) | 0.2740 | 0.1043 | 0.0086 |
| Recipient age: 65+ (ref=35-49) | 0.5704 | 0.1514 | 0.0002 |
| Recipient ethnicity: Hispanic/Latino (ref=Non-Hispanic/Non-Latino) | 0.0951 | 0.2734 | 0.7278 |
| Recipient female | 0.0883 | 0.0918 | 0.3359 |
| Recipient medical condition: hospitalized not in ICU (ref=not hospitalized) | 0.4066 | 0.2229 | 0.0681 |
| Recipient medical condition: in ICU (ref=not hospitalized) | 0.7102 | 0.7121 | 0.3186 |
| Recipient race: Asian (ref=White) | -0.6180 | 0.3930 | 0.1159 |
| Recipient race: Black (ref=White) | -0.3955 | 0.2577 | 0.1248 |
| Recipient race: Multi-racial, other, unknown or missing (ref=White) | -0.3480 | 0.2660 | 0.1909 |
| Year of ESRD treatment: missing (ref=years 3-5) | 1.2242 | 0.4608 | 0.0079 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | -0.5437 | 0.1032 | <0.0001 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | -0.3556 | 0.1199 | 0.0030 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | -0.2231 | 0.1839 | 0.2252 |
| Recipient age by recipient ethnicity interaction: 18-34 and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | -0.1742 | 0.3126 | 0.5773 |
| Recipient age by recipient ethnicity interaction: 50-64 and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | -0.1975 | 0.3047 | 0.5168 |
| Recipient age by recipient ethnicity interaction: 65+ and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | -0.1395 | 0.5112 | 0.7850 |
| Recipient sex by peak PRA interaction: female and 10-79 (ref=male and <10) | 0.3434 | 0.2196 | 0.1179 |
| Recipient sex by peak PRA interaction: female and 80+ (ref=male and <10) | -0.2128 | 0.3655 | 0.5603 |
| Recipient sex by peak PRA interaction: female and missing (ref=male and <10) | -0.5946 | 0.6204 | 0.3378 |
| * Reference for diagnosis group is glomerular diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Graft Survival Model Description | |||
| 3 Years after Transplant | |||
| Organ: Kidney | |||
| Adult (Age 18+) | |||
| 91.3% alive at 3 Years when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Congenital, Rare Familial, & Metabolic Disorders* | 0.2925 | 0.2459 | 0.2343 |
| Diagnosis: Diabetes* | 0.2634 | 0.0968 | 0.0065 |
| Diagnosis: Hypertensive Nephrosclerosis* | 0.1284 | 0.1210 | 0.2889 |
| Diagnosis: Other/Missing* | 0.2551 | 0.1131 | 0.0241 |
| Diagnosis: Polycystic Kidney Disease* | -0.3032 | 0.1666 | 0.0689 |
| Diagnosis: Renovascular & Other Vascular Diseases* | 0.5008 | 0.1570 | 0.0014 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.4057 | 0.1317 | 0.0021 |
| Donor Hispanic/Latino | -0.2691 | 0.1814 | 0.1380 |
| Donor age: 11-17 (ref==35-49) | -9.1508 | 139.7693 | 0.9478 |
| Donor age: 18-34 (ref=35-49) | -0.0337 | 0.0798 | 0.6724 |
| Donor age: 50-64 (ref=35-49) | 0.2274 | 0.0879 | 0.0097 |
| Donor age: 65+ (ref=35-49) | 0.0797 | 0.3118 | 0.7984 |
| Donor female | 0.0779 | 0.0681 | 0.2528 |
| Donor race: Asian (ref=White) | 0.3415 | 0.3930 | 0.3849 |
| Donor race: Black (ref=White) | 0.3907 | 0.2179 | 0.0730 |
| Donor race: Multi-racial, other, unknown or missing (ref=White) | 0.0624 | 0.2154 | 0.7720 |
| HLA mismatch: 0 mismatch (ref=3.5 mismatch) | -0.4679 | 0.1210 | 0.0001 |
| HLA mismatch: linear ** (ref=3.5 mismatch) | 0.0537 | 0.0263 | 0.0411 |
| HLA mismatch: missing (ref=3.5 mismatch) | -0.3753 | 0.2304 | 0.1033 |
| Ischemia time: linear (ref=average time**) | -0.0129 | 0.0189 | 0.4938 |
| Ischemia time: missing (ref=average time**) | 0.1175 | 0.4141 | 0.7766 |
| Ischemia time: quadratic (ref=average time**) | 0.0000 | 0.0006 | 0.9652 |
| Peak PRA: 10-79 (ref=<10) | 0.2196 | 0.0901 | 0.0147 |
| Peak PRA: 80-100 (ref=<10) | 0.3744 | 0.1865 | 0.0447 |
| Peak PRA: missing (ref=<10) | -0.1341 | 0.1980 | 0.4983 |
| Previous transplant of this organ type | 0.3316 | 0.1647 | 0.0441 |
| Recipient age: 18-34 (ref=35-49) | 0.1698 | 0.1287 | 0.1872 |
| Recipient age: 50-64 (ref=35-49) | 0.1764 | 0.1226 | 0.1504 |
| Recipient age: 65+ (ref=35-49) | 0.5414 | 0.1814 | 0.0028 |
| Recipient ethnicity: Hispanic/Latino (ref=Non-Hispanic/Non-Latino) | 0.0561 | 0.1699 | 0.7411 |
| Recipient female | -0.0481 | 0.1250 | 0.7004 |
| Recipient medical condition: hospitalized not in ICU (ref=not hospitalized) | -0.0372 | 0.1965 | 0.8497 |
| Recipient medical condition: in ICU (ref=not hospitalized) | 0.8403 | 0.4113 | 0.0411 |
| Recipient race: Asian (ref=White) | -0.9443 | 0.5854 | 0.1067 |
| Recipient race: Black (ref=White) | -0.0327 | 0.2497 | 0.8957 |
| Recipient race: Multi-racial, other, unknown or missing (ref=White) | 0.0054 | 0.4341 | 0.9900 |
| Year of ESRD treatment: missing (ref=years 3-5) | 2.4032 | 0.6322 | 0.0001 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | -0.3123 | 0.0935 | 0.0008 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | -0.0419 | 0.1047 | 0.6889 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | -0.4624 | 0.1702 | 0.0066 |
| Recipient age by recipient race interaction: 18-34 and Asian (ref=35-49 and White) | -0.9737 | 0.8728 | 0.2646 |
| Recipient age by recipient race interaction: 18-34 and Black (ref=35-49 and White) | 0.0191 | 0.2069 | 0.9267 |
| Recipient age by recipient race interaction: 18-34 and multi-racial/other/unknown/missing (ref=35-49 and White) | -0.2377 | 0.6536 | 0.7161 |
| Recipient age by recipient race interaction: 50-64 and Asian (ref=35-49 and White) | -0.0541 | 0.7158 | 0.9398 |
| Recipient age by recipient race interaction: 50-64 and Black (ref=35-49 and White) | -0.0543 | 0.2222 | 0.8071 |
| Recipient age by recipient race interaction: 50-64 and multi-racial/other/unknown/missing (ref=35-49 and White) | -0.1743 | 0.5880 | 0.7669 |
| Recipient age by recipient race interaction: 65+ and Asian (ref=35-49 and White) | 0.3108 | 1.1365 | 0.7845 |
| Recipient age by recipient race interaction: 65+ and Black (ref=35-49 and White) | -0.8311 | 0.4660 | 0.0745 |
| Recipient age by recipient race interaction: 65+ and multi-racial/other/unknown/missing (ref=35-49 and White) | -0.5934 | 1.0961 | 0.5883 |
| Recipient age by recipient sex interaction: 18-34 and female (ref=35-49 and male) | 0.4186 | 0.1691 | 0.0133 |
| Recipient age by recipient sex interaction: 50-64 and female (ref=35-49 and male) | 0.1533 | 0.1747 | 0.3803 |
| Recipient age by recipient sex interaction: 65+ and female (ref=35-49 and male) | 0.3585 | 0.2889 | 0.2146 |
| * Reference for diagnosis group is glomerular diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Graft Survival Model Description | |||
| 1 Month after Transplant | |||
| Organ: Kidney | |||
| Pediatric (Age 0-17) | |||
| 100.0% alive at 1 Month when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Donor age: 11-17 (ref==35-49) | -15.3479 | 8125.5120 | 0.9985 |
| Donor age: 18-34 (ref=35-49) | -0.7971 | 0.7075 | 0.2599 |
| Donor age: 50-64 (ref=35-49) | -15.5935 | 3160.2454 | 0.9961 |
| Recipient age: 0-1 (ref=2-10) | -15.5815 | 1922.9148 | 0.9935 |
| Recipient age: 11-17 (ref=2-10) | -0.6702 | 0.5411 | 0.2155 |
| Year of ESRD treatment: missing (ref=years 3-5) | -0.4597 | 9673.1240 | 1.0000 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | 15.3856 | 1731.0863 | 0.9929 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | 15.3705 | 1731.0863 | 0.9929 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | 15.2584 | 1731.0865 | 0.9930 |
| Recipient age by donor age interaction: 0-1 and 18-34 (ref=2-10 and 35-49) | 17.3908 | 1922.9150 | 0.9928 |
| Recipient age by donor age interaction: 0-1 and 50-64 (ref=2-10 and 35-49) | 33.0961 | 3699.2910 | 0.9929 |
| Recipient age by donor age interaction: 11-17 and 18-34 (ref=2-10 and 35-49) | 0.5231 | 1.0608 | 0.6219 |
| Recipient age by donor age interaction: 11-17 and 50-64 (ref=2-10 and 35-49) | 15.6120 | 3160.2456 | 0.9961 |
| * Reference for diagnosis group is congenital, familial, and metabolic kidney diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Graft Survival Model Description | |||
| 1 Year after Transplant | |||
| Organ: Kidney | |||
| Pediatric (Age 0-17) | |||
| 100.0% alive at 1 Year when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Ischemia time: linear (ref=average time**) | -32.0229 | 18.6411 | 0.0858 |
| Ischemia time: missing (ref=average time**) | 244.3848 | 145.9908 | 0.0941 |
| Ischemia time: quadratic (ref=average time**) | -1.0422 | 0.5941 | 0.0794 |
| Recipient race: Asian (ref=White) | -13.1395 | 862.6677 | 0.9878 |
| Recipient race: Black (ref=White) | 0.0438 | 0.4817 | 0.9275 |
| Recipient race: Multi-racial, other, unknown or missing (ref=White) | 1.1481 | 0.5388 | 0.0331 |
| Year of ESRD treatment: missing (ref=years 3-5) | -12.6556 | 1986.5017 | 0.9949 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | 0.3249 | 0.7332 | 0.6577 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | 0.7142 | 0.7834 | 0.3619 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | 0.9139 | 0.9175 | 0.3192 |
| * Reference for diagnosis group is congenital, familial, and metabolic kidney diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Graft Survival Model Description | |||
| 3 Years after Transplant | |||
| Organ: Kidney | |||
| Pediatric (Age 0-17) | |||
| 96.4% alive at 3 Years when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Diabetes* | -14.4053 | 5066.0508 | 0.9977 |
| Diagnosis: Focal Segmental Glomerulosclerosis* | 0.4097 | 1.1670 | 0.7255 |
| Diagnosis: Hypertensive Nephrosclerosis* | 1.4784 | 1.1934 | 0.2154 |
| Diagnosis: Other Glomerular Diseases* | 1.2195 | 0.7719 | 0.1141 |
| Diagnosis: Other/Missing* | -0.0697 | 0.9227 | 0.9398 |
| Diagnosis: Polycystic Kidney Disease* | 0.8970 | 0.9195 | 0.3293 |
| Diagnosis: Renovascular & Other Vascular Diseases* | -13.3674 | 4220.7171 | 0.9975 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.4770 | 0.9204 | 0.6043 |
| HLA mismatch: 0 mismatch (ref=3.5 mismatch) | -0.2056 | 0.5325 | 0.6995 |
| HLA mismatch: linear ** (ref=3.5 mismatch) | 0.0187 | 0.1099 | 0.8646 |
| HLA mismatch: missing (ref=3.5 mismatch) | 0.0429 | 0.5626 | 0.9392 |
| Ischemia time: linear (ref=average time**) | -0.0011 | 0.1137 | 0.9925 |
| Ischemia time: missing (ref=average time**) | -0.3586 | 2.4574 | 0.8840 |
| Ischemia time: quadratic (ref=average time**) | -0.0024 | 0.0049 | 0.6240 |
| Pre-transplant blood transfusions given: missing (ref=no) | 0.0813 | 0.3216 | 0.8003 |
| Pre-transplant blood transfusions given: yes (ref=no) | 0.1863 | 0.2695 | 0.4892 |
| Previous transplant of this organ type | 0.6516 | 0.5672 | 0.2506 |
| Recipient age: 0-1 (ref=2-10) | -0.5928 | 1.4250 | 0.6774 |
| Recipient age: 11-17 (ref=2-10) | 1.1304 | 0.6725 | 0.0928 |
| Recipient race: Asian (ref=White) | -13.9247 | 2688.4526 | 0.9959 |
| Recipient race: Black (ref=White) | 0.5434 | 0.6594 | 0.4098 |
| Recipient race: Multi-racial, other, unknown or missing (ref=White) | 0.3939 | 0.7357 | 0.5924 |
| Year of ESRD treatment: missing (ref=years 3-5) | 0.9688 | 1.1651 | 0.4057 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | 0.3672 | 0.5051 | 0.4672 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | 0.1448 | 0.5715 | 0.8000 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | 0.0196 | 0.7093 | 0.9780 |
| Recipient age by diagnosis interaction: 0-1 and FSG (ref=2-10 and congenital disease) | -13.2145 | 4116.3975 | 0.9974 |
| Recipient age by diagnosis interaction: 0-1 and diagnosis other/missing (ref=2-10 and congenital disease) | 0.9345 | 1.7084 | 0.5844 |
| Recipient age by diagnosis interaction: 0-1 and hypertensive nephrosclerosis (ref=2-10 and congenital disease) | -14.2402 | 7250.0365 | 0.9984 |
| Recipient age by diagnosis interaction: 0-1 and other glomerular diseases (ref=2-10 and congenital disease) | 1.3288 | 1.8092 | 0.4627 |
| Recipient age by diagnosis interaction: 0-1 and polycystic kidneys (ref=2-10 and congenital disease) | 2.0852 | 1.7495 | 0.2333 |
| Recipient age by diagnosis interaction: 0-1 and tubular and interstitial diseases (ref=2-10 and congenital disease) | -13.6907 | 1197.5691 | 0.9909 |
| Recipient age by diagnosis interaction: 11-17 and FSG (ref=2-10 and congenital disease) | -0.9802 | 1.3410 | 0.4648 |
| Recipient age by diagnosis interaction: 11-17 and diagnosis other/missing (ref=2-10 and congenital disease) | 0.3227 | 1.0018 | 0.7474 |
| Recipient age by diagnosis interaction: 11-17 and hypertensive nephrosclerosis (ref=2-10 and congenital disease) | -15.9920 | 1471.4977 | 0.9913 |
| Recipient age by diagnosis interaction: 11-17 and other glomerular diseases (ref=2-10 and congenital disease) | -0.9494 | 0.8655 | 0.2726 |
| Recipient age by diagnosis interaction: 11-17 and polycystic kidneys (ref=2-10 and congenital disease) | -0.2305 | 1.4096 | 0.8701 |
| Recipient age by diagnosis interaction: 11-17 and renovascular & other vascular diseases (ref=2-10 and congenital disease) | -1.2588 | 4517.4766 | 0.9998 |
| Recipient age by diagnosis interaction: 11-17 and tubular and interstitial diseases (ref=2-10 and congenital disease) | -0.0559 | 1.0180 | 0.9562 |
| Recipient age by recipient race interaction: 0-1 and Asian (ref=2-10 and white) | 19.7623 | 2688.4531 | 0.9941 |
| Recipient age by recipient race interaction: 0-1 and Black (ref=2-10 and white) | 1.9823 | 1.5782 | 0.2091 |
| Recipient age by recipient race interaction: 0-1 and multi-racial/other/unknown/missing (ref=2-10 and white) | -15.9898 | 3516.8588 | 0.9964 |
| Recipient age by recipient race interaction: 11-17 and Asian (ref=2-10 and White) | 14.9489 | 2688.4528 | 0.9956 |
| Recipient age by recipient race interaction: 11-17 and Black (ref=2-10 and White) | 0.4654 | 0.7226 | 0.5195 |
| * Reference for diagnosis group is congenital, familial, and metabolic kidney diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Patient Survival Model Description | |||
| 1 Month after First Transplant | |||
| Organ: Kidney | |||
| Adult (Age 18+) | |||
| 99.7% alive at 1 Month when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Congenital, Rare Familial, & Metabolic Disorders* | 1.8833 | 0.8072 | 0.0196 |
| Diagnosis: Diabetes* | 1.3972 | 0.4295 | 0.0011 |
| Diagnosis: Hypertensive Nephrosclerosis* | 1.2691 | 0.4693 | 0.0068 |
| Diagnosis: Other/Missing* | 0.4836 | 0.5886 | 0.4113 |
| Diagnosis: Polycystic Kidney Disease* | 0.3845 | 0.6341 | 0.5443 |
| Diagnosis: Renovascular & Other Vascular Diseases* | 0.6254 | 0.6937 | 0.3673 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.2386 | 0.8040 | 0.7666 |
| Donor age: 11-17 (ref==35-49) | -1.2433 | 15416.2922 | 0.9999 |
| Donor age: 18-34 (ref=35-49) | -0.3667 | 0.5795 | 0.5268 |
| Donor age: 50-64 (ref=35-49) | -14.1197 | 753.4887 | 0.9850 |
| Donor age: 65+ (ref=35-49) | -14.0271 | 2848.0310 | 0.9961 |
| Peak PRA: 10-79 (ref=<10) | 0.3100 | 0.3369 | 0.3575 |
| Peak PRA: 80-100 (ref=<10) | 0.4514 | 0.7257 | 0.5339 |
| Peak PRA: missing (ref=<10) | 0.4827 | 0.7472 | 0.5183 |
| Recipient age: 18-34 (ref=35-49) | -14.1894 | 579.4723 | 0.9805 |
| Recipient age: 50-64 (ref=35-49) | 0.1555 | 0.4309 | 0.7182 |
| Recipient age: 65+ (ref=35-49) | 0.3921 | 0.5374 | 0.4656 |
| Recipient medical condition: hospitalized not in ICU (ref=not hospitalized) | 1.2316 | 0.5182 | 0.0175 |
| Recipient medical condition: in ICU (ref=not hospitalized) | -13.7801 | 3758.2925 | 0.9971 |
| Year of ESRD treatment: missing (ref=years 3-5) | 3.0628 | 0.6445 | <0.0001 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | -0.9266 | 0.3053 | 0.0024 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | -0.5423 | 0.3411 | 0.1119 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | 0.4326 | 0.6261 | 0.4895 |
| Recipient age by donor age interaction: 18-34 and 18-34 (ref=35-49 and 35-49) | 14.2144 | 579.4727 | 0.9804 |
| Recipient age by donor age interaction: 18-34 and 50-64 (ref=35-49 and 35-49) | 27.5409 | 950.5442 | 0.9769 |
| Recipient age by donor age interaction: 18-34 and 65+ (ref=35-49 and 35-49) | 13.9819 | 8131.3228 | 0.9986 |
| Recipient age by donor age interaction: 50-64 and 18-34 (ref=35-49 and 35-49) | 0.6320 | 0.7211 | 0.3808 |
| Recipient age by donor age interaction: 50-64 and 50-64 (ref=35-49 and 35-49) | 14.7547 | 753.4889 | 0.9844 |
| Recipient age by donor age interaction: 50-64 and 65+ (ref=35-49 and 35-49) | -0.3698 | 4125.3281 | 0.9999 |
| Recipient age by donor age interaction: 65+ and 18-34 (ref=35-49 and 35-49) | 0.2350 | 1.2410 | 0.8498 |
| Recipient age by donor age interaction: 65+ and 50-64 (ref=35-49 and 35-49) | 15.3492 | 753.4890 | 0.9837 |
| Recipient age by donor age interaction: 65+ and 65+ (ref=35-49 and 35-49) | 15.5503 | 2848.0312 | 0.9956 |
| * Reference for diagnosis group is glomerular diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Patient Survival Model Description | |||
| 1 Year after First Transplant | |||
| Organ: Kidney | |||
| Adult (Age 18+) | |||
| 97.7% alive at 1 Year when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Congenital, Rare Familial, & Metabolic Disorders* | 0.4351 | 0.5215 | 0.4041 |
| Diagnosis: Diabetes* | 0.6928 | 0.1759 | 0.0001 |
| Diagnosis: Hypertensive Nephrosclerosis* | 0.4249 | 0.2124 | 0.0454 |
| Diagnosis: Other/Missing* | 0.4979 | 0.2209 | 0.0242 |
| Diagnosis: Polycystic Kidney Disease* | -0.6014 | 0.3249 | 0.0642 |
| Diagnosis: Renovascular & Other Vascular Diseases* | 0.2713 | 0.2992 | 0.3645 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.3465 | 0.2882 | 0.2292 |
| Donor age: 11-17 (ref==35-49) | -9.5817 | 977.5986 | 0.9922 |
| Donor age: 18-34 (ref=35-49) | -0.0423 | 0.1445 | 0.7697 |
| Donor age: 50-64 (ref=35-49) | 0.0369 | 0.1614 | 0.8194 |
| Donor age: 65+ (ref=35-49) | 0.0737 | 0.4633 | 0.8736 |
| Donor race: Asian (ref=White) | 1.1634 | 0.5175 | 0.0246 |
| Donor race: Black (ref=White) | 0.2096 | 0.3728 | 0.5740 |
| Donor race: Multi-racial, other, unknown or missing (ref=White) | 0.9309 | 0.4112 | 0.0236 |
| HLA mismatch: 0 mismatch (ref=3.5 mismatch) | -0.4826 | 0.2534 | 0.0568 |
| HLA mismatch: linear ** (ref=3.5 mismatch) | 0.1391 | 0.0462 | 0.0026 |
| HLA mismatch: missing (ref=3.5 mismatch) | 0.0795 | 0.3776 | 0.8333 |
| Peak PRA: 10-79 (ref=<10) | 0.1485 | 0.1705 | 0.3840 |
| Peak PRA: 80-100 (ref=<10) | 0.4612 | 0.3646 | 0.2059 |
| Peak PRA: missing (ref=<10) | 0.5484 | 0.3818 | 0.1509 |
| Recipient age: 18-34 (ref=35-49) | -0.4993 | 0.2359 | 0.0343 |
| Recipient age: 50-64 (ref=35-49) | 0.7320 | 0.1540 | <0.0001 |
| Recipient age: 65+ (ref=35-49) | 1.1230 | 0.1969 | <0.0001 |
| Recipient ethnicity: Hispanic/Latino (ref=Non-Hispanic/Non-Latino) | -0.1191 | 0.1909 | 0.5328 |
| Recipient medical condition: hospitalized not in ICU (ref=not hospitalized) | 0.7098 | 0.3090 | 0.0216 |
| Recipient medical condition: in ICU (ref=not hospitalized) | -10.3687 | 280.2961 | 0.9705 |
| Recipient race: Asian (ref=White) | -1.1894 | 0.5694 | 0.0367 |
| Recipient race: Black (ref=White) | -0.3327 | 0.3655 | 0.3627 |
| Recipient race: Multi-racial, other, unknown or missing (ref=White) | -1.0827 | 0.4632 | 0.0194 |
| Year of ESRD treatment: missing (ref=years 3-5) | 1.5100 | 0.6013 | 0.0120 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | -0.9137 | 0.1482 | <0.0001 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | -0.5378 | 0.1643 | 0.0011 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | 0.3678 | 0.3012 | 0.2222 |
| * Reference for diagnosis group is glomerular diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||
| Living Donor Patient Survival Model Description | |||
| 3 Years after First Transplant | |||
| Organ: Kidney | |||
| Adult (Age 18+) | |||
| 94.1% alive at 3 Years when all covariates=0. | |||
| Patient Characteristic Covariates | beta | standard error | p-value |
| Diagnosis: Congenital, Rare Familial, & Metabolic Disorders* | 0.5726 | 0.3958 | 0.1479 |
| Diagnosis: Diabetes* | 0.7532 | 0.1369 | <0.0001 |
| Diagnosis: Hypertensive Nephrosclerosis* | -0.0487 | 0.1952 | 0.8029 |
| Diagnosis: Other/Missing* | 0.2907 | 0.1917 | 0.1293 |
| Diagnosis: Polycystic Kidney Disease* | -0.1032 | 0.2250 | 0.6464 |
| Diagnosis: Renovascular & Other Vascular Diseases* | 0.6346 | 0.2227 | 0.0044 |
| Diagnosis: Tubular and Interstitial Diseases* | 0.4716 | 0.2084 | 0.0236 |
| Donor Hispanic/Latino | -0.1348 | 0.2789 | 0.6289 |
| Donor age: 11-17 (ref==35-49) | -9.6737 | 256.4892 | 0.9699 |
| Donor age: 18-34 (ref=35-49) | -0.0114 | 0.1171 | 0.9228 |
| Donor age: 50-64 (ref=35-49) | 0.0645 | 0.1297 | 0.6190 |
| Donor age: 65+ (ref=35-49) | 0.0621 | 0.3921 | 0.8741 |
| Donor race: Asian (ref=White) | 0.7939 | 0.4875 | 0.1034 |
| Donor race: Black (ref=White) | 0.1050 | 0.3287 | 0.7494 |
| Donor race: Multi-racial, other, unknown or missing (ref=White) | 0.4971 | 0.2799 | 0.0758 |
| Peak PRA: 10-79 (ref=<10) | -0.1336 | 0.1527 | 0.3815 |
| Peak PRA: 80-100 (ref=<10) | 0.1069 | 0.3624 | 0.7680 |
| Peak PRA: missing (ref=<10) | -0.0713 | 0.2566 | 0.7810 |
| Recipient age: 18-34 (ref=35-49) | -0.3898 | 0.1700 | 0.0219 |
| Recipient age: 50-64 (ref=35-49) | 0.5878 | 0.1246 | <0.0001 |
| Recipient age: 65+ (ref=35-49) | 1.1673 | 0.1699 | <0.0001 |
| Recipient ethnicity: Hispanic/Latino (ref=Non-Hispanic/Non-Latino) | -0.6223 | 0.4195 | 0.1380 |
| Recipient race: Asian (ref=White) | -1.2974 | 0.5507 | 0.0185 |
| Recipient race: Black (ref=White) | -0.0605 | 0.3205 | 0.8503 |
| Recipient race: Multi-racial, other, unknown or missing (ref=White) | -0.6691 | 0.4129 | 0.1051 |
| Year of ESRD treatment: missing (ref=years 3-5) | 1.8529 | 0.7270 | 0.0108 |
| Year of ESRD treatment: year 1 (ref=years 3-5) | -0.7317 | 0.1248 | <0.0001 |
| Year of ESRD treatment: year 2 (ref=years 3-5) | -0.4572 | 0.1419 | 0.0013 |
| Year of ESRD treatment: years 6+ (ref=years 3-5) | 0.1614 | 0.2971 | 0.5869 |
| Recipient age by recipient ethnicity interaction: 18-34 and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | -0.0540 | 0.5941 | 0.9275 |
| Recipient age by recipient ethnicity interaction: 50-64 and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | 0.1596 | 0.4602 | 0.7287 |
| Recipient age by recipient ethnicity interaction: 65+ and Hispanic/Latino (ref=35-49 and Non-Hispanic/Non-Latino) | 0.1563 | 0.6404 | 0.8072 |
| * Reference for diagnosis group is glomerular diseases. | |||
| ** HLA is centered on 3.5; ischemia time is centered on 17.82 hours. | |||